Biomaterials for Cancer Therapeutics

<p>1. Cancer: so common and so difficult to deal with<br>2. Phenotypic evolution of cancer cells: structural requirements for survival<br>3. Immunoactive drug carriers in cancer therapy<br>4. Treating cancer by delivering drug nanocrystals<br>5. Polymer therapeutics<br>6. pH-sensitive biomaterials for cancer therapy and diagnosis<br>7. Nucleic acid anticancer agents<br>8. Biomaterials for gene editing therapeutics<br>9. Liquid biopsies for early cancer detection<br>10. Nanotechnology for cancer screening and diagnosis: from innovations to clinical applications<br>11. Advances and clinical challenges in biomaterials for in vivo tumor imaging<br>12. Macroscopic fluorescence lifetime-based Fo ¨rster resonance energy transfer imaging for quantitative ligandreceptor binding<br>13. Suppression of cancer stem cells<br>14. Comparison of two- and three-dimensional cancer models for assessing potential cancer therapeutics<br>15. Engineered tumor models for cancer biology and treatment<br>16. Cancer mechanobiology: interaction of biomaterials with cancer cells<br>17. Immunostimulatory materials<br>18. Biomaterials for cancer immunotherapy<br>19. Lymph node targeting for improved potency of cancer vaccine<br>20. Immunogenic clearance-mediated cancer vaccination<br>21. The future of drug delivery in cancer treatment<br>22. Development of clinically effective formulations for anticancer applications: why it is so difficult?</p>